Your Article Summary
See Latest ArticlesImmunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)
Modern Pathology, 09/24/07
Lerma, E., et al. - Basal breast carcinomas triple negative for estrogen receptors, progesterone receptors and Her2/neu breast carcinomas are more aggressive than conventional neoplasms. We studied 64 cases with immunohistochemistry, using 23 antibodies, to characterize diverse pathological pathways. A basal cytokeratin was identified in 81% of tumors and vimentin was identified in 55%. The mean Ki67 index was 46% (range, 10–90%)
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Mammographic Determination of Breast Volume by Elliptical Cone Estimation
World Journal of Surgery, 12/01/09
Multiple 18F-FDG, PET-CT for Postoperative Monitoring of Breast Cancer Patients
Acta Radiologica, 12/01/09
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer
Annals of Oncology, 12/01/09